Tag #Fatty Liver Disease

Showing 1 to 4 of 4 results

dailymail.co.uk

🌐 90% Global Worthiness

Sep 15, 22:19

Novel Polymer Trap Shows Promise Against Type 2 Diabetes and Fatty Liver Disease

Canadian researchers developed a biodegradable polymer that traps D-lactate, a gut bacteria byproduct linked to type 2 diabetes and fatty liver disease, in obese mice, improving blood sugar control and liver health without dietary changes.

Novel Polymer Trap Shows Promise Against Type 2 Diabetes and Fatty Liver Disease

Canadian researchers developed a biodegradable polymer that traps D-lactate, a gut bacteria byproduct linked to type 2 diabetes and fatty liver disease, in obese mice, improving blood sugar control and liver health without dietary changes.

Progress

24% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How does the polymer trap work to mitigate the negative effects of D-lactate?

The biodegradable polymer binds to D-lactate in the intestines, forming a complex too large to be absorbed into the bloodstream. This prevents D-lactate from reaching the liver, thus stopping its overproduction of glucose and fat, and reducing inflammation. The complex is then excreted in the feces.

abcnews.go.com

🌐 85% Global Worthiness

May 1, 04:13

Wegovy Ingredient Shows Promise in Treating Fatty Liver Disease

Research published in the New England Journal of Medicine shows that semaglutide, the active ingredient in Wegovy, significantly reduced liver inflammation and scarring in patients with metabolic dysfunction-associated steatohepatitis (MASH), a fatty liver disease affecting an estimated 1.5% to 6.5%...

Wegovy Ingredient Shows Promise in Treating Fatty Liver Disease

Research published in the New England Journal of Medicine shows that semaglutide, the active ingredient in Wegovy, significantly reduced liver inflammation and scarring in patients with metabolic dysfunction-associated steatohepatitis (MASH), a fatty liver disease affecting an estimated 1.5% to 6.5%...

Progress

48% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the significance of semaglutide's effectiveness in reducing liver inflammation and scarring in patients with MASH?

New research shows the Wegovy active ingredient, semaglutide, significantly reduced liver inflammation in about two-thirds and scarring in one-third of patients with MASH, a fatty liver disease affecting 1.5% to 6.5% of U.S. adults. Patients also lost an average of 8.5% of their body weight over 72 weeks. This is important because MASH can lead to liver failure, cancer, and death.

theguardian.com

🌐 85% Global Worthiness

Jun 5, 16:15

15 Million Undiagnosed Cases of Aggressive Fatty Liver Disease in US and Europe

Research reveals that over 15 million people in the US, UK, Germany, and France are undiagnosed with metabolic dysfunction-associated steatohepatitis (MASH), the most aggressive form of fatty liver disease, resulting in significant economic and health consequences; improved screening, treatment, and...

15 Million Undiagnosed Cases of Aggressive Fatty Liver Disease in US and Europe

Research reveals that over 15 million people in the US, UK, Germany, and France are undiagnosed with metabolic dysfunction-associated steatohepatitis (MASH), the most aggressive form of fatty liver disease, resulting in significant economic and health consequences; improved screening, treatment, and...

Progress

40% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the economic and health consequences of the significant underdiagnosis of MASH, and what actions are proposed to mitigate these effects?

The study reveals a significant underdiagnosis of MASH across the US and Europe, with diagnosis rates below 18% despite a prevalence of nearly 3-4% in the studied populations. This underdiagnosis has substantial economic consequences, with predicted healthcare costs tripling in the next 20 years if diagnosis rates don't improve. The lack of awareness translates to billions of pounds in lost productivity and compromised health.

faz.net

🌐 85% Global Worthiness

Dec 13, 20:05

Teen Sues Food Giants for Allegedly Causing Type 2 Diabetes

A Pennsylvania teenager is suing major food corporations—Kraft Heinz, Mondelez, Nestle, Mars, Coca-Cola, and PepsiCo—for allegedly causing his type 2 diabetes and fatty liver disease through processed foods containing addictive substances and targeted marketing towards children, a lawsuit that coinc...

Teen Sues Food Giants for Allegedly Causing Type 2 Diabetes

A Pennsylvania teenager is suing major food corporations—Kraft Heinz, Mondelez, Nestle, Mars, Coca-Cola, and PepsiCo—for allegedly causing his type 2 diabetes and fatty liver disease through processed foods containing addictive substances and targeted marketing towards children, a lawsuit that coinc...

Progress

48% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the potential long-term impacts of this lawsuit on the processed food industry, public health policies, and future litigation?

This lawsuit could trigger significant changes in the food industry and public health policies. The FDA's stance on addictive processed foods, combined with Kennedy's proposed policies, suggests a potential future crackdown on unhealthy food marketing and ingredients. The success of this lawsuit could also lead to more similar actions and increased regulation of the processed food industry.

Showing 1 to 4 of 4 results